SCHEMBL34461724

SCHEMBL34461724

O=C(O)Cn1c2ccn(-c3ccccc3[N+](=O)[O-])c2c(=O)n2nnnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIK1 P39086 7/20 0.39
▸ GRIK2 Q13002 7/20 0.39
▸ GRIK5 Q16478 7/20 0.39
▸ GRIK3 Q13003 6/20 0.39
▸ GRIA1 P42261 5/20 0.39
▸ GRIA2 P42262 5/20 0.39
▸ GRIA3 P42263 5/20 0.39
▸ GRIA4 P48058 5/20 0.39
▸ GRIK4 Q16099 4/20 0.39
▸ SLC22A6 Q4U2R8 1/20 0.35
▸ SLC22A8 Q8TCC7 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ FAAH O00519 1/20 0.34
▸ MGLL Q99685 1/20 0.34
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ HCAR1 Q9BXC0 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MITF O75030 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34461772 0.87 CYP1A2 (0.35) ALDH1A1FAAHMGLLMEN1KMT2A
SCHEMBL34461790 0.86 HCAR1 (0.33) ALDH1A1FAAHMGLLKMT2AHCAR1
SCHEMBL34461723 0.83 TRPA1 (0.42) ALDH1A1MEN1KMT2APOLB
SCHEMBL34461760 0.83 GRIA1 (0.32) GRIA1GRIA2GRIA3GRIA4ALDH1A1
SCHEMBL34461744 0.82 ALDH1A1 (0.37) GRIK1GRIK2GRIK5GRIK3GRIA1
SCHEMBL34461739 0.70 TRPA1 (0.43) ALDH1A1MEN1KMT2APOLB
SCHEMBL34461734 0.69 ALDH1A1 (0.36) ALDH1A1FAAHMGLLKMT2AHCAR1
SCHEMBL34461733 0.69 ADORA2A (0.38) ALDH1A1HCAR1POLBMAPK1
SCHEMBL34461729 0.66 ALDH1A1 (0.35) ALDH1A1KMT2AMAPK1
SCHEMBL260928 0.64 APEX1 (0.57) GRIK1GRIK2GRIK5GRIK3GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260098041-A1 FUSED BICYCLIC PYRIMIDONES AS WRN INHIBITORS INCYTE CORPORATION (US) 2026-04-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098041-A1 FUSED BICYCLIC PYRIMIDONES AS WRN INHIBITORS WRN, POLR1A, REV1 GRIK1 2336/4885GRIK2 4306/4885GRIK5 4321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback